{"result": "(\"entity\"<|>HORMONA DEL CRECIMIENTO<|>EVENT<|>Growth hormone is a hormone produced by the pituitary gland that is involved in growth and metabolism, and its excess is a key factor in acromegaly.)\n##\n(\"entity\"<|>TUMORES HIPOFISARIOS<|>EVENT<|>Pituitary tumors are abnormal growths in the pituitary gland that can lead to conditions such as acromegaly by producing excess growth hormone.)\n##\n(\"entity\"<|>HYPERPROLACTINEMIA<|>EVENT<|>Hyperprolactinemia is a condition characterized by elevated levels of prolactin, which can occur in patients with acromegaly due to hormonal interactions.)\n##\n(\"entity\"<|>CARDIOVASCULARES<|>EVENT<|>Cardiovascular comorbidities are health issues related to the heart and blood vessels that are frequently associated with acromegaly and contribute to mortality.)\n##\n(\"relationship\"<|>ACROMEGALIA<|>HORMONA DEL CRECIMIENTO<|>Acromegaly is caused by excess growth hormone, which is produced by the pituitary gland.<|>9)\n##\n(\"relationship\"<|>ACROMEGALIA<|>TUMORES HIPOFISARIOS<|>Pituitary tumors can lead to acromegaly by secreting excess growth hormone.<|>8)\n##\n(\"relationship\"<|>ACROMEGALIA<|>HYPERPROLACTINEMIA<|>Patients with acromegaly may experience hyperprolactinemia due to hormonal interactions from pituitary tumors.<|>6)\n##\n(\"relationship\"<|>ACROMEGALIA<|>CARDIOVASCULARES<|>Acromegaly is associated with various cardiovascular comorbidities that increase mortality risk.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ctica de diagnóstico y tratamiento de la acromegalia. Endocrinol Nutr. 2013;60(8):457.e1-15.                   pecífica de las células corticotropas, por lo que no se relacionaría con tumores productores\n        • Ho PJ, Friberg RD, Barkan Al. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with            de GH (opción D falsa).\n          acromegaly. J Clin Endocrinol Metab. 1992;75(3):812-9.\n        • Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al; Endocrine Society. Acromegaly: an endocrine society clinical\n          practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-51.                                                                         Referencias:\n                                                                                                                                                    • Castaño l, Martínez de la Piscina I, Portillo N, Rica I. Adenomas hipofisarios: Impacto clínico de los hallazgos moleculares. Rev Esp\n                                                                                                                                                      Endocrinol Pediatr. 2017;8(Suppl):35-45.\n                                                                                                                                                    • Clemente Gallego D, Ramírez de Molina V, Lucas Morante T. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Espa-\n    50  ¿Cuál de los siguientes eventos no parece estar relacionado patogénicamente con                                                               ñola de Endocrinología y Nutrición; 2015. Capítulo 13. Hipersecreción de hormona del crecimiento: Acromegalia y gigantismo [citado\n                                                                                                                                                      29 de abril de 2019]. Disponible en: https://manual.seen.es/article?id=55114b66-489c-4c70-8a67-2bcdac18103c\n        el desarrollo de un tumor productor de GH?                                                                                                  • Snyder PJ. Causes of hypopituitarism. En: Cooper DS, Martin KA, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.\n                                                                                                                                                      com (acceso 29 de abril de 2019).\n        A. Hiperexpresión de PTTG (pituitary tumor transforming gene).\n        B. Microduplicación Xq26.3.\n        C. Mutación activadora de la subunidad α de la proteína estimuladora de los nucleótidos                                                 51  ¿Cuál de las siguientes afirmaciones es incorrecta respecto a la acromegalia?\n             de guanina (GSα).                                                                                                                      A. En el 30% de los pacientes existe algún grado de hiperprolactinemia, ya sea por\n        D.   Mutación activadora del gen que codifica T-Pit.                                                                                            cosecreción o por distorsión del tallo hipofisario.\n                                                                                                                                                    B. Aunque la densidad mineral ósea (DMO) por DEXA puede estar aumentada, hay un\n        COMENTARIO                                                                                                                                      aumento de la fragilidad vertebral.\n                                                                                                                                                    C. Metabólicamente cursa con retención de nitrógeno, antagonismo insulínico\n        En gen PTTG se sobreexpresa en la mayoría de los adenomas hipofisarios, y en concreto                                                           y lipogénesis.\n        puede aparecer en adenomas somatotropos (respuesta A).                                                                                      D.  La causa más frecuente de mortalidad es la enfermedad cardiovascular.\n\n\n\n60                                                                                                                                                                                                                                                                               61\n---\n                                                                                                                                                                                                                              HIPÓFISIS  1\n\n\n\n    COMENTARIO                                                                                                                         52  Señale la afirmación incorrecta respecto al tratamiento de la acromegalia:\n    Entre un 20% y un 40% de los pacientes acromegálicos presentan hiperprolactinemia, bien                                                A. Ante un microadenoma productor de GH, la cirugía transesfenoidal es la opción\n    en relación con cosecreción hormonal por el tumor o por compresión local del tallo hipofi-                                                 terapéutica de elección.\n    sario por el adenoma (respuesta A).                                                                                                    B. Ante un macroadenoma invasivo que comprime el quiasma, el tratamiento primario\n    La acromegalia asocia comorbilidades que pueden deberse al exceso de GH-IGF-1 per se, al                                                   con análogos de somatostatina es el de primera elección.\n    efecto local tumoral o al desarrollo de déficits de otras hormonas hipofisarias.                                                       C. En pacientes con acromegalia curada quirúrgicamente, la tasa de recurrencias a largo\n    Principales comorbilidades asociadas a la acromegalia:                                                                                     plazo es de entre un 3% y un 8%.\n    •  Cardiovasculares: son las que se relacionan más frecuentemente con mortalidad (38-62%                                               D.  Los somatotropinomas densamente granulados, en comparación con los escasamente\n       de las causas de mortalidad en la acromegalia) (respuesta D). Incluyen la hipertensión                                                  granulados, son de menor tamaño, tienen una mayor tasa de secreción de GH y\n                                                                                                                                               responden mejor\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ACROMEGALIA<|>EVENT<|>Acromegalia is a hormonal disorder that results from excess growth hormone, leading to abnormal growth and various comorbidities.)\n##\n(\"entity\"<|>HIPÓFISIS<|>ORGANIZATION<|>The pituitary gland, or hypophysis, is responsible for producing growth hormone and is often involved in acromegaly cases.)\n##\n(\"entity\"<|>SOCIETY ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Spanish Society of Endocrinology and Nutrition provides clinical practice guidelines for conditions like acromegaly.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital of Spain and the location of the Spanish Society of Endocrinology and Nutrition.)\n##\n(\"entity\"<|>SNYDER PJ<|>PERSON<|>Snyder PJ is an author referenced in the context of hypopituitarism and its causes.)\n##\n(\"entity\"<|>KATZNELSON L<|>PERSON<|>Katznelson L is an author who contributed to the clinical practice guidelines for acromegaly.)\n##\n(\"entity\"<|>MURAD MH<|>PERSON<|>Murad MH is an author involved in the clinical practice guidelines for acromegaly.)\n##\n(\"entity\"<|>MELMED S<|>PERSON<|>Melmed S is an author who has contributed to the understanding and treatment of acromegaly.)\n##\n(\"relationship\"<|>HIPÓFISIS<|>ACROMEGALIA<|>The pituitary gland is responsible for the secretion of growth hormone, which is directly related to the condition of acromegaly.<|>8)\n##\n(\"relationship\"<|>SOCIETY ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ACROMEGALIA<|>The Spanish Society of Endocrinology and Nutrition provides guidelines and information regarding the treatment and management of acromegaly.<|>7)\n##\n(\"relationship\"<|>KATZNELSON L<|>SOCIETY ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Katznelson L is an author of the clinical practice guidelines published by the Spanish Society of Endocrinology and Nutrition regarding acromegaly.<|>6)\n##\n(\"relationship\"<|>MELMED S<|>SOCIETY ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Melmed S is an author of the clinical practice guidelines published by the Spanish Society of Endocrinology and Nutrition regarding acromegaly.<|>6)\n##\n(\"relationship\"<|>MURAD MH<|>SOCIETY ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Murad MH is an author of the clinical practice guidelines published by the Spanish Society of Endocrinology and Nutrition regarding acromegaly.<|>6)\n##\n(\"relationship\"<|>SNYDER PJ<|>HIPÓFISIS<|>Snyder PJ discusses causes of hypopituitarism, which can be related to the functioning of the pituitary gland.<|>5)\n<|COMPLETE|>"}]}